TY - JOUR
T1 - Colchicine for large pericardial effusion
AU - Adler, Yehuda
AU - Guindo, Josep
AU - Finkelstein, Yaron
AU - Khouri, Asaad
AU - Assali, Abid
AU - Bayes-Genis, Antoni
AU - De Luna, Antony Bayes
PY - 1998
Y1 - 1998
N2 - On the basis of our reported experience with colchicine for recurrent pericarditis, we administered colchicine to two patients with large pericardial effusions complicating idiopathic pericarditis. The first was a 26-year-old male who showed clinical deterioration following emergency pericardiocentesis and aspirin (3 g/day) for 10 days; the second was a 2- year-old girl who was unsuccessfully treated with aspirin (100 mg/kg/day) for 2 weeks, followed by corticosteroids for 7 months. Administration of colchicine (1 mg/day) instead of aspirin in the first case, and with a rapid tapering-off of the corticosteroids in the second case, led to complete regression of the pericardial effusion on echocardiography within 1 week and 1 month, respectively. Colchicine was discontinued after 1 month in the first patient and was continued for 6 months in the child. Neither has had a recurrence at 24 and 6 months of follow-up, respectively. No side effects of colchicine were observed. We conclude that colchicine may be effective in the treatment of large pericardial effusion when therapy with nonsteroidal anti- inflammatory drags and/or corticosteroids fails.
AB - On the basis of our reported experience with colchicine for recurrent pericarditis, we administered colchicine to two patients with large pericardial effusions complicating idiopathic pericarditis. The first was a 26-year-old male who showed clinical deterioration following emergency pericardiocentesis and aspirin (3 g/day) for 10 days; the second was a 2- year-old girl who was unsuccessfully treated with aspirin (100 mg/kg/day) for 2 weeks, followed by corticosteroids for 7 months. Administration of colchicine (1 mg/day) instead of aspirin in the first case, and with a rapid tapering-off of the corticosteroids in the second case, led to complete regression of the pericardial effusion on echocardiography within 1 week and 1 month, respectively. Colchicine was discontinued after 1 month in the first patient and was continued for 6 months in the child. Neither has had a recurrence at 24 and 6 months of follow-up, respectively. No side effects of colchicine were observed. We conclude that colchicine may be effective in the treatment of large pericardial effusion when therapy with nonsteroidal anti- inflammatory drags and/or corticosteroids fails.
KW - Colchicine
KW - Pericardial effusion
KW - Recurrent pericarditis
UR - http://www.scopus.com/inward/record.url?scp=0031952450&partnerID=8YFLogxK
U2 - 10.1002/clc.4960210220
DO - 10.1002/clc.4960210220
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9491960
AN - SCOPUS:0031952450
VL - 21
SP - 143
EP - 144
JO - Clinical Cardiology
JF - Clinical Cardiology
SN - 0160-9289
IS - 2
ER -